U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H21N2.Cl
Molecular Weight 312.836
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEPIDILINE A

SMILES

[Cl-].CC1=C(C)[N+](CC2=CC=CC=C2)=CN1CC3=CC=CC=C3

InChI

InChIKey=ZATWGHMQWRXUNZ-UHFFFAOYSA-M
InChI=1S/C19H21N2.ClH/c1-16-17(2)21(14-19-11-7-4-8-12-19)15-20(16)13-18-9-5-3-6-10-18;/h3-12,15H,13-14H2,1-2H3;1H/q+1;/p-1

HIDE SMILES / InChI

Molecular Formula C19H21N2
Molecular Weight 277.3834
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 10:44:02 GMT 2023
Edited
by admin
on Sat Dec 16 10:44:02 GMT 2023
Record UNII
29S9F3SV9Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LEPIDILINE A
Common Name English
1H-IMIDAZOLIUM, 4,5-DIMETHYL-1,3-BIS(PHENYLMETHYL)-, CHLORIDE (1:1)
Systematic Name English
MACALINE A
Common Name English
1,3-DIBENZYL-4,5-DIMETHYLIMIDAZOLIUM CHLORIDE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID70851687
Created by admin on Sat Dec 16 10:44:02 GMT 2023 , Edited by admin on Sat Dec 16 10:44:02 GMT 2023
PRIMARY
CAS
596093-98-0
Created by admin on Sat Dec 16 10:44:02 GMT 2023 , Edited by admin on Sat Dec 16 10:44:02 GMT 2023
PRIMARY
PUBCHEM
404702
Created by admin on Sat Dec 16 10:44:02 GMT 2023 , Edited by admin on Sat Dec 16 10:44:02 GMT 2023
PRIMARY
FDA UNII
29S9F3SV9Q
Created by admin on Sat Dec 16 10:44:02 GMT 2023 , Edited by admin on Sat Dec 16 10:44:02 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
Results were expressed as ED50 values (ug/mL) and are as follows: human lung carcinoma(A549) >10; human bladder carcinoma(UMUC3) = >10; human colon adenocarcinoma(HT-29) >10; human prostate adenocarcinoma(PC3) >10; human pancreatic adenocarcinoma(PACA2) >10; human kidney carcinoma(A4982LM) >10; human breast carcinoma(MDA231) >10; human ovarian carcinoma(FDIGROV) = 7.39.